Business Wire

PA-PMI

12.9.2019 15:02:08 CEST | Business Wire | Press release

Share
PMI Study Reveals Top Productivity-Boosting AI Technologies, According to Project Managers

Project Management Institute (PMI) today released its 2019 Pulse of the Profession® In-Depth Report: AI @ Work: New Projects, New Thinking. The report, a companion piece to AI Innovators: Cracking the Code on Project Performance , explores how artificial intelligence (AI) is changing the way projects are managed and delivered globally.

As AI projects become the norm, project managers need to better understand what technologies will help them streamline and improve their AI-based project work -- or they risk being left behind. The new report highlights the top AI technologies project leaders are currently leveraging to boost project management productivity, and how to incorporate AI technologies into their overall project work.

While project leaders are tapping into AI technologies to boost project productivity and quality, unlocking AI’s full potential requires building and constantly refreshing knowledge of emerging technologies. In fact, the report finds that organizations and their project leaders will need a high Project Management Technology Quotient (PMTQ) – a way of evaluating an organization’s ability to manage and integrate technology based on the needs of the organization or the project at hand – to turn AI strategy into reality.

“In today’s increasingly project-based economy, the most forward-thinking organizations know that the success of their strategies hinges on how well they can execute projects. And the race toward AI mastery is no exception,” said Michael DePrisco, vice president of global solutions at PMI. “As we see AI technologies continue to be integrated into organizations, the research indicates that project managers, especially those with a high PMTQ, are well prepared to play an integral role in implementation.”

Of the respondents to the study, 50 percent reported a high PMTQ (Innovators) and 10 percent reported only sometimes or never practicing the principles of the PMTQ (Laggards).

A majority of both groups say their project management skills and experience are a good foundation for managing AI. But the Innovators have the upper hand: 74 percent of Innovators say they’re confident their current skill set enables them to work with AI, compared with 51 percent of Laggards.

Even more so, Innovators cite having more awareness and experience with several AI technologies, including knowledge-based systems, decision management, speech recognition, and expert systems. These respondents also report delivering better outcomes when using AI technologies, including a decreased amount of time spent on activities like monitoring progress, managing documentation, as well as activity and resource planning.

The top technologies respondents cite as enhancing productivity are:

  • Robotic process automation: Technology that mimics and automates human tasks to support corporate processes.
  • Machine learning: Technology that allows computers to learn by employing pattern detection for improved decisions in subsequent situations.
  • Reinforcement learning: A machine learning technique that enables software to learn in an interactive environment by trial and error using feedback from its own actions.

The top technologies respondents identify as increasing quality are:

  • Anti-bias solutions: Technology that automatically identifies bias in a range of AI algorithms.
  • Expert systems: Technology that emulates and mimics human intelligence, skills or behavior and usually offers expert knowledge in a particular field, topic, or skill.
  • Knowledge-based systems: Technology that understands the context of the data being processed to help problem-solve procedures and support human learning, decision making, and actions.

While it is clear AI can make a difference in value delivery, it is up to organizations and their project leaders to identify and understand which technologies can best help them achieve their specific goals and deliver long-term success.

Read more about 2019 Pulse of the Profession® In-Depth Report: AI Innovators: AI @ Work: New Projects, New Thinking. The Pulse of the Profession® In-Depth research was conducted online in June/July 2019 among 780 project management practitioners globally.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Founded in 1969, PMI delivers value for more than three million professionals working in nearly every country in the world through global advocacy, collaboration, education and research. We advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye